May 24, 2019
David H Sachs, MD, a renowned transplant immunologist at Columbia University Medical Center and Massachusetts General Hospital, will serve as a key consultant in guiding the testing and development of Stemson Therapeutics’ hair growth cell therapy. Dr. Sachs brings over 45 years of experience in testing transplantation tolerance of allografts and xenografts. He is the author of over 700 articles in scientific journals and has pioneered the development of animal models to test transplantation tolerance.
Read More »
April 15, 2019
Stemson Therapeutics has established its headquarters in La Jolla, CA on the Sanford Burnham Prebys Medical Discovery Institute (SBP) campus, centered in one of the premier biomedical research hubs in the United States. Stemson’s unique cell therapy solution to treat alopecia is based on Induced Pluripotent Stem Cell (iPSC) technology originally developed at SBP by Stemson co-founder, Dr. Alexey Terskikh. By incubating within the institute, Stemson will have access to world class research and development facilities to support the final product development in preparation for clinical trials.
Read More »
March 14, 2019
Matt Posard, former senior executive at Illumina, has joined the Stemson Therapeutics team as Executive Chairman of the Board. Matt brings over 30 years of executive experience in the life sciences industry. He helped grow three companies – BioSite, GenProbe and Illumina – from early stage commercialization to major global success. He is a seasoned board member and currently serves on multiple boards including Halozyme Therapeutics (NASDAQ: HALO), Dermtech, Talis BioMedical, Ingite Bio, and Fabric Genomics.
Read More »
January 1, 2019
Stemson Therapeutics welcomes Dr. Hideyuki Okano and Dr. Michael Rendl as scientific advisors, as well as Dr. Richard Chaffoo and Dr. Paul McAndrews as medical advisors. Okano is a stem cell biologist with deep experience in Induced Pluripotent Stem Cells (iPSC) and their translation into therapeutic use. Dr. Rendl is a stem cell biologist focusing on hair follicle formation. Together, Drs. Okano and Rendl will guide the scientific and biological development of the Stemson Therapeutics hair growth cell therapy.
Read More »
